Compound Evidence File
#EC-2026-0046
Glutathione
Filed under Peptides. The bureau holds 162 laboratory returns for this compound from 56 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
56 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Mar 2026 | 18 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 10.0 | 10.0 | 23 Feb 2026 | 8 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 10.0 | 10.0 | 19 Apr 2026 | 22 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 19 Feb 2026 | 5 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 10.0 | 10.0 | 4 Feb 2026 | 20 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 10.0 | 10.0 | 10 Jan 2026 | 11 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Apr 2026 | 16 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 10.0 | 10.0 | 10.0 | 16 Dec 2025 | 17 Mar 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Jan 2026 | 10 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Jun 2026 | 5 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 10.0 | 10.0 | 10.0 | 22 Jul 2026 | 7 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Jul 2026 | 7 Jul 2026 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 10.0 | 10.0 | 10.0 | 9 Jun 2025 | 9 Jun 2025 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 9.9 | 9.9 | 9.9 | 14 Mar 2026 | 27 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Nov 2025 | 28 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Dec 2025 | 13 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Jan 2026 | 19 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Feb 2026 | 1 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 9.9 | 12 May 2026 | 1 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Jan 2026 | 23 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 5 Mar 2026 | 3 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 12 Feb 2026 | 7 Apr 2026 |
| Glamgurcraft Innovations Foreign TradeCASE #VI-2026-0348 | X | 1 | 9.6 | 9.6 | 9.6 | 8 Jul 2025 | 8 Jul 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 9.4 | 9.4 | 9.4 | 28 Mar 2025 | 28 Mar 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.9 | 7.3 | 9.7 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.7 | 7.3 | 9.8 | 21 May 2026 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.4 | 7.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 2 | 8.3 | 6.7 | 10.0 | 2 Apr 2025 | 21 May 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 8.3 | 8.3 | 8.3 | 6 May 2025 | 6 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.0 | 6.8 | 9.8 | 24 May 2026 | 24 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 | 11 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 7.8 | 6.7 | 8.9 | 24 May 2026 | 24 May 2026 |
| Xingruida XDRCASE #VI-2026-0898 | X | 6 | 7.6 | 5.5 | 9.7 | 27 Feb 2025 | 21 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.4 | 7.4 | 7.4 | 24 Apr 2025 | 24 Apr 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 7.4 | 7.4 | 7.4 | 6 May 2025 | 6 May 2025 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 8 | 7.3 | 5.7 | 8.7 | 13 Feb 2025 | 21 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 11 | 7.0 | 3.8 | 10.0 | 28 Mar 2025 | 26 Jan 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 1 | 6.9 | 6.9 | 6.9 | 13 Feb 2025 | 13 Feb 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 14 | 6.8 | 4.4 | 8.9 | 13 Feb 2025 | 17 May 2026 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 6.3 | 6.3 | 6.3 | 27 Feb 2025 | 27 Feb 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 6.0 | 6.0 | 6.0 | 14 Jan 2025 | 14 Jan 2025 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 6.0 | 6.0 | 6.0 | 17 Dec 2024 | 17 Dec 2024 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 6.0 | 6.0 | 6.0 | 8 Jul 2025 | 8 Jul 2025 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 | 24 Apr 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 5.9 | 5.9 | 5.9 | 27 Feb 2025 | 27 Feb 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 5.5 | 5.5 | 5.5 | 7 May 2025 | 7 May 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 3 | 5.3 | 3.6 | 6.1 | 16 Mar 2025 | 26 Jan 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 5.3 | 5.3 | 5.3 | 13 Jun 2025 | 13 Jun 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 5.3 | 5.3 | 5.3 | 3 Jun 2025 | 3 Jun 2025 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 3.9 | 2.8 | 4.9 | 7 May 2025 | 24 May 2026 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 3.5 | 3.5 | 3.5 | 20 Jun 2025 | 20 Jun 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 3.1 | 3.1 | 3.1 | 9 Jun 2025 | 9 Jun 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 3.1 | 3.1 | 3.1 | 25 Apr 2025 | 25 Apr 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 25 Apr 2025 |
Open any subject to view the batch-level evidence for Glutathione alone.